机构:[1]Beijing Tiantan Hospital , Capital Medical University, BeiJing, Beijing, China (People's Republic)首都医科大学附属天坛医院[2]Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine, Shanghai, Shanghai, China (People's Republic)[3]Xiangya Hospital Central South University, Changsha, Hunan, China (People's Republic)[4]The Third People's Hospital of Zhengzhou, Zhengzhou, Henan, China (People's Republic)[5]Shandong Cancer Hospital & Institute, Jinan, Shandong, China (People's Republic)[6]Xuanwu Hospital Capital Medical University, Beijing, Beijing, China (People's Republic)首都医科大学宣武医院[7]Beijing Tiantan Hospital, Capital Medical University, BeiJing, Beijing, China (People's Republic)首都医科大学附属天坛医院[8]Xiangya Hospital Central South University, Changsha, Henan, China (People's Republic)[9]West China School of Medicine/West China Hospital of Sichuan University, Chengdu, Sichuan, China (People's Republic)[10]Peking Union Medical College Hospital, BeiJing, Beijing, China (People's Republic)
第一作者机构:[1]Beijing Tiantan Hospital , Capital Medical University, BeiJing, Beijing, China (People's Republic)
推荐引用方式(GB/T 7714):
Qiu Xiaoguang,Jiang Mawei,Liu Chao,et al.NIMOTUZUMAB COMBINED WITH CONCURRENT CHEMORADIOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)[J].NEURO-ONCOLOGY.2023,25:
APA:
Qiu, Xiaoguang,Jiang, Mawei,Liu, Chao,Wang, Gang,Tao, Rongjie...&Wang, Yu.(2023).NIMOTUZUMAB COMBINED WITH CONCURRENT CHEMORADIOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG).NEURO-ONCOLOGY,25,
MLA:
Qiu, Xiaoguang,et al."NIMOTUZUMAB COMBINED WITH CONCURRENT CHEMORADIOTHERAPY IN THE TREATMENT OF NEWLY DIAGNOSED PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)".NEURO-ONCOLOGY 25.(2023)